Clinical trial Recruiting at 1 site Interventional Ages 16 and up

Study of brain activity in patients with Tourette Syndrome

Official title: Multimodal Electrophysiological Study of Cortico-subcortical Biomarkers of Tics in Tourette Syndrome

Run by University Hospital, Bordeaux · NCT06909656 · Data updated 2026-11-12

This study is testing how brain activity changes in adults with severe Tourette Syndrome who are getting deep brain stimulation to better understand their tics.

Quick facts

Study typeInterventional
Ages16 Years and up
SexAll
Enrollment10 (estimated)
SponsorUniversity Hospital, Bordeaux
Academic / other
Locations1 site (Bordeaux)
StatusRecruiting
StartedFebruary 17, 2025
Main results expectedFebruary 17, 2027
Study endsFebruary 17, 2027
Registry record updatedApril 3, 2025
Trial IDNCT06909656 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are individuals aged 16 and older with disabling and drug-resistant Tourette Syndrome who are receiving deep brain stimulation.

Probably not a fit

Patients with major depressive syndrome or significant brain abnormalities may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the electrophysiological characteristics of brain activity in individuals with Tourette Syndrome (TS) who are undergoing deep brain stimulation treatment. By utilizing multimodal electrophysiological recordings, the research aims to identify specific cortico-subcortical biomarkers associated with tics. The study focuses on patients aged 16 and older who have disabling and drug-resistant TS, providing insights into the underlying mechanisms of the disorder. The findings could enhance understanding of TS and inform future treatment strategies.

Why it matters

Potential benefit: If successful, this study could lead to improved treatment options for patients with Tourette Syndrome.

How similar studies have gone: Other studies have explored electrophysiological approaches in neurological disorders, suggesting potential for success in this area.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patient at least 16 years old.
* Disabling and drug-resistant Tourette's syndrome.
* Receiving deep brain stimulation treatment with implantation of the PERCEPT™ Device as part of their medical management.
* Normal brain MRI.
* Subject affiliated or beneficiary of a social security system.
* Free and informed consent of the patient and, for minors, of the minor and at least one parental authority.

Exclusion Criteria:

* Major depressive syndrome (Beck Depression Inventory (BDI-II) \> 20).
* MRI showing significant brain atrophy or significant hyperintensities.
* Pregnant or nursing mothers.
* Person unable to give personal consent.
* Person subject to a legal protection measure (curatorship, guardianship) or placed under court protection.
* Patient included in another research protocol with an interdiction of participation to another research or in an exclusion period

Where it's running

  • CHU de Bordeaux
    Bordeaux, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.